MiR-331-3p regulates expression of neuropilin-2 in glioblastoma

Journal of Neuro-Oncology

Volumn 116, Issue 1, 2014, Pages 67-75

  Epis, Michael R ^a   Giles, Keith M ^a   Candy, Patrick A ^a,b   Webster, Rebecca J ^a   Leedman, Peter J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Glioblastoma multiforme; microRNA; miR 331 3p; Neuropilin 2

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 331 3P; NEUROPILIN 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLIOBLASTOMA; IN VITRO STUDY; NRP 2 GENE; RNA INTERFERENCE; TRANSIENT EXPRESSION; UPREGULATION;

BRAIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC LIBRARY; GLIOBLASTOMA; HUMANS; LINEAR MODELS; MICRORNAS; NEUROPILIN-2; NORANDROSTANES; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 84891829380     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1271-7     Document Type: Article

References (38)

1. Bai RY, Staedtke V, Riggins GJ (2011) Molecular targeting of glioblastoma: drug discovery and therapies. Trends Mol Med 17:301-312. doi: 10.1016/j.molmed.2011.01.011
2. Mao H, Lebrun DG, Yang J, Zhu VF, Li M (2012) Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest 30:48-56. doi: 10.3109/07357907.2011.630050
3. Nikaki A, Piperi C, Papavassiliou AG (2012) Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy. Expert Opin Investig Drugs 21:1475-1488. doi: 10.1517/13543784.2012.710199
4. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033. doi: 10.1158/0008-5472.CAN-05-0137
5. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM (2008) microRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28:5369-5380. doi: 10.1128/MCB.00479-08
6. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen CF, Ambros VR, Israel MA (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67:2456-2468. doi: 10.1158/0008-5472.Can-06-2698
7. Wong ST, Zhang XQ, Zhuang JT, Chan HL, Li CH, Leung GK (2012) microRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells. Anticancer Res 32:2835-2841
8. Lee ST, Chu K, Oh HJ, Im WS, Lim JY, Kim SK, Park CK, Jung KH, Lee SK, Kim M, Roh JK (2012) Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J Neurooncol 102:19-24
9. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, Lopes B, Schiff D, Purow B, Abounader R (2009) microRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 69:7569-7576. doi: 10.1158/0008-5472.CAN-09-0529
10. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ (2009) Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 284:5731-5741. doi: 10.1074/jbc.M804280200
11. Purow B (2011) The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma? J Neurooncol 103:429-436
12. Epis MR, Giles KM, Barker A, Kendrick TS, Leedman PJ (2009) miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. J Biol Chem 284:24696-24704
13. Wang L, Tang H, Thayanithy V, Subramanian S, Oberg AL, Cunningham JM, Cerhan JR, Steer CJ, Thibodeau SN (2009) Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res 69:9490-9497. doi: 10.1158/0008-5472.CAN-09-2183
14. Epis MR, Giles KM, Kalinowski FC, Barker A, Cohen RJ, Leedman PJ (2012) Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells. J Biol Chem 287:35251-35259
15. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408
16. Giles KM, Barker A, Zhang PM, Epis MR, Leedman PJ (2011) microRNA regulation of growth factor receptor signaling in human cancer cells. Methods Mol Biol 676:147-163
17. Kalinowski FC, Giles KM, Candy PA, Ali A, Ganda C, Epis MR, Webster RJ, Leedman PJ (2012) Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7. PLoS ONE 7:e47067. doi: 10.1371/journal.pone.0047067
18. Giles KM, Brown RA, Epis MR, Kalinowski FC, Leedman PJ (2013) miRNA-7-5p inhibits melanoma cell migration and invasion. Biochem Biophys Res Commun 430:706-710. doi: 10.1016/j.bbrc.2012.11.086
19. Cancer Genome Atlas Research N (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068. doi: 10.1038/nature07385
20. Ihaka R, Gentleman R (1996) R: a language for data analysis and graphics. J Comput Graph Stat 5:299-314
21. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20. doi: 10.1016/j.cell.2004.12.035
22. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM, Wei JS, Giese A, Berens ME (2001) Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 53:161-176
23. Moller HG, Rasmussen AP, Andersen HH, Johnsen KB, Henriksen M, Duroux M (2013) A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol 47:131-144. doi: 10.1007/s12035-012-8349-7
24. Watanabe T, Hirota Y, Arakawa Y, Fujisawa H, Tachibana O, Hasegawa M, Yamashita J, Hayashi Y (2003) Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma. Brain Pathol 13:431-439
25. White NM, Youssef YM, Fendler A, Stephan C, Jung K, Yousef GM (2012) The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer. Biol Chem 393:379-389. doi: 10.1515/hsz-2011-0246
26. Guo X, Guo L, Ji J, Zhang J, Zhang J, Chen X, Cai Q, Li J, Gu Q, Liu B, Zhu Z, Yu Y (2010) miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun 398:1-6. doi: 10.1016/j.bbrc.2010.05.082
27. Park JH, Aravind L, Wolff EC, Kaevel J, Kim YS, Park MH (2006) Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme. Proc Natl Acad Sci USA 103:51-56
28. Preukschas M, Hagel C, Schulte A, Weber K, Lamszus K, Sievert H, Pallmann N, Bokemeyer C, Hauber J, Braig M, Balabanov S (2012) Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. PLoS ONE 7:e43468. doi: 10.1371/journal.pone.0043468
29. Fakhari M, Pullirsch D, Abraham D, Paya K, Hofbauer R, Holzfeind P, Hofmann M, Aharinejad S (2002) Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma. Cancer 94:258-263
30. Goel HL, Chang C, Pursell B, Leav I, Lyle S, Xi HS, Hsieh CC, Adisetiyo H, Roy-Burman P, Coleman IM, Nelson PS, Vessella RL, Davis RJ, Plymate SR, Mercurio AM (2012) VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer. Cancer Discov 2:906-921. doi: 10.1158/2159-8290.CD-12-0085
31. Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P, Ohgaki H (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57:684-689
32. Goel HL, Pursell B, Chang C, Shaw LM, Mao J, Simin K, Kumar P, Vander Kooi CW, Shultz LD, Greiner DL, Norum JH, Toftgard R, Kuperwasser C, Mercurio AM (2013) GLI1 regulates a novel neuropilin-2/alpha6beta1 integrin based autocrine pathway that contributes to breast cancer initiation. EMBO Mol Med 5:488-508. doi: 10.1002/emmm.201202078
33. Goel HL, Pursell B, Standley C, Fogarty K, Mercurio AM (2012) Neuropilin-2 regulates alpha6beta1 integrin in the formation of focal adhesions and signaling. J Cell Sci 125:497-506. doi: 10.1242/jcs.094433
34. Yasuoka H, Kodama R, Tsujimoto M, Yoshidome K, Akamatsu H, Nakahara M, Inagaki M, Sanke T, Nakamura Y (2009) Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression. BMC cancer 9:220. doi: 10.1186/1471-2407-9-220
35. Yasuoka H, Kodama R, Hirokawa M, Takamura Y, Miyauchi A, Inagaki M, Sanke T, Nakamura Y (2011) Neuropilin-2 expression in papillary thyroid carcinoma: correlation with VEGF-D expression, lymph node metastasis, and VEGF-D-induced aggressive cancer cell phenotype. J Clin Endocrinol Metab 96:E1857-E1861. doi: 10.1210/jc.2011-1180
36. Geretti E, van Meeteren LA, Shimizu A, Dudley AC, Claesson-Welsh L, Klagsbrun M (2010) A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression. Mol Cancer Res 8:1063-1073. doi: 10.1158/1541-7786.MCR-10-0157
37. Specenier P (2012) Bevacizumab in glioblastoma multiforme. Expert Rev Anticancer Ther 12:9-18. doi: 10.1586/era.11.179
38. Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, Mangala LS, Arumugam T, Logsdon CD, Lopez-Berestein G, Sood AK, Ellis LM (2008) Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl Cancer Inst 100:109-120. doi: 10.1093/jnci/djm279